Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine for Post-episiotomy Perineal Pain
NCT03084549Phase 3Completed
- Sponsor
- CHD Vendée
- Start
- Oct 2017
- Primary completion
- Nov 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of ropivacaine in perineal pain, sponsored by CHD Vendée. Started Oct 2017; status: completed.
02
Drugs
ropivacaine
03
Conditions
perineal pain
Beyond the preview
Go deeper on NCT03084549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03084549.